BioSpace News Archive

OmniAb, Inc. (NASDAQ: OABI) announced the launch of OmniDeep™ at the 19th Annual PEGS Boston Conference and Expo: The Essential Protein Engineering & Cell Therapy Summit.

Ainos, Inc. announced the appointment of Ms. Meng-Lin Sung to the position of Chief Financial Officer, effective May 17, 2023.

Cabaletta Bio, Inc. announced the pricing of an underwritten public offering of 7,250,000 shares of its common stock at a public offering price of $12.00 per share.

CANbridge Pharmaceuticals Inc. announced that data on a novel second-generation spinal muscular atrophy gene therapy, developed under the CANbridge and UMass Chan Medical School research agreement, was presented as a poster at the American Society of Gene and Cell Therapy 26th Annual Meeting, in Los Angeles.

FzioMed, Inc., a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, announced the appointment of industry veteran Alex DiNello to its Board of Directors whose appointment became effective May 1, 2023.

Verismo Therapeutics today announced that Sara Weiss has joined the company as Senior Vice President of Clinical Operations.

Distribution Agreement Grants Pentec Exclusive Distribution Rights for Altemia Lobe’s Novel Sickle Cell Anemia Medical Food.

Micron Biomedical today announced positive Phase 1/2 data from the first-ever clinical trial of microarray technology in children including infants as young as 9 months old.

Spanish biopharmaceutical company Biofabri, a subsidiary of Zendal, and IAVI, an international nonprofit research organization focused on developing vaccines and antibodies against infectious and neglected diseases, today announced the signing of an agreement for end-to-end development of the tuberculosis (TB) vaccine candidate MTBVAC.

Kelonia Therapeutics today announced the results of preclinical research demonstrating that its in vivo Gene Placement System (iGPS™) technology efficiently delivered CAR molecules specifically to T cells at therapeutic dose levels in both mice and non-human primates (NHPs).